Translational Breast Cancer

Translational Breast Cancer Research Consortium Trial 022 – Annals of Oncology

Annals of Oncology made the following post on X:

“New article in press: Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022.

Waterfall plots displaying the best RANO-BM CNS responses.”

Translational Breast Cancer Research Consortium Trial 022 - Annals of Oncology”

Read the study.
Source: Annals of Oncology/X

Ado-Trastuzumab-Emtansine Annals of Oncology brain metastases Breast Cancer cancer clinical trials HER2-positive Neratinib OncoDaily Oncology RANO-BM translational research